About this trial
The purpose of this study is to establish a registry database for patients undergoing anesthesia for cardiovascular surgery or procedures in our operating or hybrid room. The following information will be collected:
1. Preoperative patient assessment 2. All monitored perioperative biosignal data 3. Intraoperative and immediate postoperative hemodynamic information, input/output balance, and medication usage 4. Short- and long-term prognosis from electronic medical records This database will be used to develop a vigilant monitoring system that integrates multiple biosignal data simultaneously, contributing to the improvement of anesthesia care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults age 19 and older
Patients scheduled for anesthesia at a cardiovascular hospital for cardiovascular surgery or procedures
Disqualifiers
None
Trial population
Patients undergoing cardio/neurovascular surgery or procedure
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
all cause mortality
All-cause mortality within one year after surgery
Secondary outcomes
Postprocedural myocardial infarction
Defined by an increase in CK-MB or cardiac troponin (cTn) levels.
Acute kidney injury
The definition of AKI refers to the Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group's KDIGO Clinical Practice Guideline for Acute Kidney Injury.
surgical re-exploration
require a return to the operating room for bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason
deep sternal wound infection
infection involving muscle, bone, or mediastinum requiring operative intervention
Sponsors and contacts
Click on the lead sponsor to view all of their trials.